The FDA’s public letter to 23andMe said the FDA was “concerned about the public health consequences of inaccurate results.” Since the FDA came down on them, Wojcicki and her company have bowed to the pressure. Now their tests promise only ancestor information and a file with the raw data. An update on their website reads: “We intend to add some genetic-related health reports once we have a comprehensive product offering. At this time we do not know which health reports might be available or when they might be available.”
